Granulomatous interstitial nephritis due to sarcoidosis following SARS-CoV-2 infection: a rare case report.

Granulomatous interstitial nephritis due to sarcoidosis following SARS-CoV-2 infection: a rare case report.

Publication date: Jun 16, 2025

We report the first documented case of renal sarcoidosis developing after SARS-CoV-2 infection. The patient, a 59-year-old woman with no significant medical history, was diagnosed with COVID-19 after experiencing persistent fatigue and insomnia. Approximately three weeks after the infection, she developed a skin rash, prompting a biopsy that revealed epithelioid granulomas. A systemic evaluation using computed tomography identified enlarged bilateral hilar lymph nodes, and a needle aspiration biopsy confirmed the presence of epithelioid granulomas, leading to a diagnosis of sarcoidosis. Nine months after recovering from COVID-19, she was referred to the nephrology department due to progressive renal dysfunction. A renal biopsy demonstrated granulomatous interstitial nephritis with Schaumann bodies, consistent with renal sarcoidosis. Treatment with prednisolone (30 mg/day, 0. 5 mg/kg/day) resulted in significant improvement in renal function, suggesting a potential link between SARS-CoV-2 infection and immune dysregulation. This case highlights the importance of monitoring renal function in patients with post-COVID-19 sarcoidosis, even in the absence of disease progression in other organs.

Concepts Keywords
30mg COVID-19
Biopsy Interstitial nephritis
Dysregulation Sarcoidosis
Prednisolone SARS-CoV-2
Renal

Semantics

Type Source Name
disease MESH interstitial nephritis
disease MESH sarcoidosis
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease IDO history
disease MESH insomnia
disease MESH infection
disease MESH granulomas
drug DRUGBANK Prednisolone
disease MESH disease progression

Original Article

(Visited 1 times, 1 visits today)